- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 10-04-2026: Press Release
10-04-2026 | 07:49 pm
10-04-2026 | 07:49 pm
Lupin launched Dapagliflozin Tablets (generic Farxiga) in the United States. This strategic move expands its US product portfolio, introducing a new anti-diabetic option with potential for revenue growth in a key market.
No comments yet. Be the first to comment!